Skip to main content
SpringerLink
Log in

Diversity of nephrogenic diabetes insipidus mutations and importance of early recognition and treatment

  • Frontiers of Nephrology
  • Part 1: Molecular Basis of Genetic Disorders (Continued From Vol. 2 No. 3)
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bichet D. Nephrogenic diabetes insipidus. In: Davison A, Cameron J, Grünfeld J, Kerr D, Ritz E, Winearls C (eds) Oxford textbook of clinical nephrology. Vol 2. New York: Oxford University Press, 1998:1095–1109.

    Google Scholar 

  2. Bichet DG, Oksche A, Rosenthal W. Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1997;8: 1951–1958.

    CAS  PubMed  Google Scholar 

  3. Vargas-Poussou R, Forestier L, Dautzenberg MD, Niaudet P, Déchaud M, Antignac C. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1997;8:1855–1862.

    CAS  PubMed  Google Scholar 

  4. Knoers NV, van den Oweland AK, Verdijk M, Monnens LA, van Oost BA. Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. Kidney Int 1994;46(1):170–176.

    Article  CAS  PubMed  Google Scholar 

  5. Oksche A, Dickson J, Schülein R, Seyberth HW, Müller M, Rascher W, Birnbaumer M, Rosenthal W. Two novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus. Biophys Biochem Res Com 1994;205:552–557.

    Article  CAS  Google Scholar 

  6. Wildin RS, Antush MJ, Bennett RL, Schoof JM, Scott CR. HeterogeneousAVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet 1994;55(2):266–277.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Yuasa H, Ito M, Oiso Y, Kurokawa M, Watanabe T, Oda Y, Ishizuka T, Tani N, Ito S, Shibata A, Saito H. Novel mutations in the V2 vasopressin receptor gene in two pedigrees with congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metab 1994;79(2):361–365.

    CAS  PubMed  Google Scholar 

  8. Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M. Biochemical basis of partial NDI phenotypes. Mol Endocrinol 1997;11:1806–1813.

    Article  CAS  PubMed  Google Scholar 

  9. Bichet DG, Bimbaumer M, Lonergan M, Arthus M-F, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New M, DiBona FJ, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K. Nature and recurrence ofAVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 1994;55:278–286.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Jinnouchi H, Araki E, Miyamura N, Kishikawa H, Yoshimura R, Isami S, Yamaguchi K, Iwamatsu H, Shichiri M. Analysis of vasopressin receptor type II (V2R) gene in three Japanese pedigrees with congenital nephrogenic diabetes insipidus: identification of a family with complete deletion of the V2R gene. Eur J Endocrinol 1996;134(6):689–698.

    Article  CAS  PubMed  Google Scholar 

  11. Bichet DG, Arthus M-F, Lonergan M, Hendy GN, Paradis AJ, Fujiwara TM, Morgan K, Gregory MC, Rosenthal W, Didwania A, Antaramian A, Birnbaumer M. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 1993;92:1262–1268.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Holtzman EJ, Harris HWJ, Kolakowski LFJ, Guay-Woodford LM, Botelho B, Ausiello DA. Brief report: a molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N Engl J Med 1993;328(21):1534–1537.

    Article  CAS  PubMed  Google Scholar 

  13. Wenkert D, Merendino JJJ, Shenker A, Thambi N, Robertson GL, Moses AM, Spiegel AM. Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus. Hum Mol Genet 1994;3(8):1429–1430.

    Article  CAS  PubMed  Google Scholar 

  14. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet 1992;2(2):103–106.

    Article  CAS  PubMed  Google Scholar 

  15. Faa V, Ventruto ML, Loche S, Bozzola M, Podda R, Cao A, Rosatelli MC. Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus. Hum Mol Genet 1994;3(9):1685–1686.

    Article  CAS  PubMed  Google Scholar 

  16. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus M-F, Hendy GN, Birnbaumer M, Bichet DG. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 1992; 359(6392):233–235.

    Article  CAS  PubMed  Google Scholar 

  17. Shoji Y, Takahashi T, Suzuki Y, Suzuki T, Komatsu K, Hirono H, Shoji Y, Yokoyama T, Kito H, Takada G. Mutational analyses ofAVPR2 gene in three Japanese families with X-linked nephrogenic diabetes insipidus two recurrent mutations, R137H and delta V278, caused by the hypermutability at CpG dinucleotides. Hum Mutat 1998;suppl (6):S278-S283.

    Article  Google Scholar 

  18. Tsukaguchi H, Matsubara H, Aritaki S, Kimura T, Abe S, Inada M. Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Biochem Biophys Res Commun 1993;197(2):1000–1010.

    Article  CAS  PubMed  Google Scholar 

  19. Van den Ouweland AM, Dreesen JC, Verdijk M, Knoers NV, Monnens LA, Rocchi M, van Oost BA. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 1992;2(2):99–102.

    Article  PubMed  Google Scholar 

  20. Tsukaguchi H, Matsubara H, Inada M. Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus. Kidney Int 1995;48(2):554–562.

    Article  CAS  PubMed  Google Scholar 

  21. Yokoyama K, Yamauchi A, Izumi M, Itoh, T, Ando A, Imai E, Kamada T, Ueda N. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 1996;7(3):410–414.

    CAS  PubMed  Google Scholar 

  22. Cheong FH, Park HW, Ha IS, Moon HN, Choi Y, Ko KW, Jun JK. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus. Nephron 1997;75(4):431–437.

    Article  CAS  PubMed  Google Scholar 

  23. van Lieburg AF, Verdijk MAJ, Schoute F, Ligtenberg MJL, van Oost BA, Waldhauser F, Dobner M, Monnens LAH, Knoers NVAM. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 1995;96: 70–78.

    Article  PubMed  Google Scholar 

  24. Friedman E, Bale AE, Carson E, Boson WL, Nordenskjold M, Ritzen M, Ferreira PC, Jammal A, De Marco L. Nephrogenic diabetes insipidus: an X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal. Proc Natl Acad Sci USA 1994;91(18):8457–8461.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Tajima T, Nakae J, Takekoshi Y, Takahashi Y, Yuri K, Nagashima T, Fujieda K. Three novelAVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus. Pediatr Res 1996;39(3):522–526.

    Article  CAS  PubMed  Google Scholar 

  26. Holtzman EJ, Kolakowski LF, O'Brien D, Crawford JD, Ausiello DA. A null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred. Hum Mol Genet 1993;2:1201–1204.

    Article  CAS  PubMed  Google Scholar 

  27. Holtzman EJ, Kolakowski LFJ, Geifman-Holtzman O, O'Brien DG, Rasoulpour M, Guillot AP, Ausiello DA. Mutations in the vasopressin V2 receptor gene in two families with nephrogenic diabetes insipidus. J Am Soc Nephrol 1994; 5(2):169–176.

    CAS  PubMed  Google Scholar 

  28. Merendino JJJ, Speigel AM, Crawford JD, O'Carroll AM, Brownstein MJ, Lolait SJ. Brief report: a mutation in the vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. N Engl J Med 1993;328(21):1538–1541.

    Article  CAS  PubMed  Google Scholar 

  29. Nomura Y, Onigata K, Nagashima T, Yutani S, Mochizuki H, Nagashima K, Morikawa A. Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 1997;82(10):3434–3437.

    Article  CAS  PubMed  Google Scholar 

  30. Pan Y, Wilson P, Gitschier J. The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin. J Biol Chem 1994; 269(50):31933–31937.

    CAS  PubMed  Google Scholar 

  31. Oksche A, Moller A, Dickson J, Rosendahl W, Rascher W, Bichet DG, Rosenthal W. Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus. Hum Genet 1996;98(5):587–589.

    Article  CAS  PubMed  Google Scholar 

  32. Beaudet A, Tsui L-C. A suggested nomenclature for designating mutations. Hum Mutat 1993;2:245–248.

    Article  CAS  PubMed  Google Scholar 

  33. Antonarakis S. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 1998;11(1):1–3.

    Article  CAS  PubMed  Google Scholar 

  34. Mouillac B, Chini B, Balestre M-N, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M. The binding site of neuropeptide vasopressin V1a receptor. J Biol Chem 1995;270:25771–25777.

    Article  CAS  PubMed  Google Scholar 

  35. Sharif M, Hanley M. Stepping up the pressure. Nature 1992;357:279–280.

    Article  CAS  PubMed  Google Scholar 

  36. Ala Y, Morin D, Sabatier N, Vargas R, Cotte N, Déchaux M, Antignac C, Arthus M-F, Lonergan M, Turner MS, Balestre M-N, Alonso G, Hibert M, Barberis C, Hendy GN, Bichet DG, Jard S. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 1998 (in press).

  37. Mulders SM, Bichet DG, Rijss JPL, Kamsteeg E-J, Arthus M-F, Lonergan M, Fujiwara M, Morgan K, Leijendekker R, van der Sluijs P, van Os CH, Deen PMT. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 1998;102:57–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Litwack G, Schmidt TJ. Biochemistry of hormones I: polypeptide hormones. In: Devlin TM (ed). Textbook of biochemistry with clinical correlations. 4th ed. New York: Wiley-Liss, 1997:839–891.

    Google Scholar 

  39. Bichet DG. In: Spiegel AM (ed) Nephrogenic diabetes insipidus and vasopressin receptor mutations. Totowa, New Jersey: Humana Press, 1997:170–182.

    Google Scholar 

  40. Chini B, Mouillac B, Ala Y, Balestre M-N, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M. Tyr 115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J 1995;14:2176–2182.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Shayakul C, Knepper MA, Smith CP, DiGiovanni SR, Hediger MA. Segmental localization of urea transporter mRNAs in rat kidney. Am J Physiol 1997;272(5 Pt 2):F654-F660.

    CAS  PubMed  Google Scholar 

  42. Walz T, Hirai T, Murata K, Heymann JB, Mitsuoka K, Fujiyoshi Y, Smith BL, Agre P, Engel A. The three-dimensional structure of aquaporin-1. Nature 1997;387: 624–627.

    Article  CAS  PubMed  Google Scholar 

  43. Cheng A, van Hoek AN, Yeager M, Verkman AS, Mitra AK. Three-dimensional organization of a human water channel. Nature 1997;387:627–630.

    Article  CAS  PubMed  Google Scholar 

  44. Agre P, Preston GM, Smith BL, Jung JS, Raina S, Moon C, Guggino WB, Nielsen S. Aquaporin CHIP: the archetypal molecular water channel. Am J Physiol 1993; 34:F463-F476.

    Google Scholar 

  45. Lee MD, King LS, Agre P. The aquaporin family of water channel proteins in clinical medicine. Medicine 1997; 76(3):141–156.

    Article  CAS  PubMed  Google Scholar 

  46. Birnbaumer M, Seibold A, Gilbert, S, Ishido M, Barberis C, Antaramian A, Brabet P. Molecular cloning of the receptor for human antidiuretic hormone. Nature 1992; 357:333–335.

    Article  CAS  PubMed  Google Scholar 

  47. Seibold A, Brabet P, Rosenthal W, Bimbaumer M. Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet 1992; 51:1078–1083.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Crawford JD, Bode HH. Disorders of the posterior pituitary in children. In: Gardner LI (ed) Endocrine and genetic diseases of childhood and adolescence. 2nd ed. Philadelphia: WB Saunders, 1975:126–158.

    Google Scholar 

  49. Forssman H. On the mode of hereditary transmission in diabetes insipidus. Nordisk Med 1942;16:3211–3213.

    Google Scholar 

  50. Waring AG, Kajdi L, Tappan V. Congenital defect of water metabolism. Am J Dis Child 1945;69:323–325.

    Google Scholar 

  51. Williams RK, Henry C. Nephrogenic diabetes insipidus transmitted by females and appearing during infancy in males. Ann Int Med 1947;27:84–95.

    Article  CAS  PubMed  Google Scholar 

  52. Niaudet P, Dechaux M, Trivin C, Loirat C, Broyer M. Nephrogenic diabetes insipidus: clinical and pathophysiological aspects. Adv Nephrol Necker Hosp 1984; 13:247–260.

    CAS  PubMed  Google Scholar 

  53. McIlraith CH. Notes on some cases of diabetes insipidus with marked family and hereditary tendencies. Lancet 1892;2:767–768.

    Article  Google Scholar 

  54. Reeves WB, Andreoli TE. Nephrogenic diabetes insipidus. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. 7th ed. New York: McGraw-Hill, 1995:3045–3071.

    Google Scholar 

  55. Lacombe UL. De la polydipsie [Thesis of Medicine, no. 99]. Imprimerie et Fonderie de Rignoux; 1841.

  56. Weil A. Ueber die hereditare form des diabetes insipidus. Archives fur Pathologische Anatornie und Physiologie and fur Klinische Medicine (Virchow's Arch) 1884;95:70–95.

    Google Scholar 

  57. Camerer JW. Eine ergänzung des Weilschen diabetes-insipidus-stammbaumes. Archiv für Rassen-und Gesellschaftshygiene Biologie 1935;28:382–385.

    Google Scholar 

  58. Dölle W. Eine weitere ergänzung des Weilschen diabetes-insipidus-stammbaurnes. Zeitschrift für Menschliche Vererbungs-und Konstitutionslehre 1951;30:372–374.

    Google Scholar 

  59. Weil A. Ueber die hereditare form des diabetes insipidus. Deutches Archiv fur Klinische Medizin 1908;93: 190–290.

    Google Scholar 

  60. Rittig R, Robertson GL, Siggaard C, Kovacs L, Gregersen N, Nyborg J, Pedersen E. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet 1996;58:107–117.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Streitz JMJ, Streitz JM. Polyuric urinary tract dilatation with renal damage. J Urol 1988,139:784–785.

    Article  PubMed  Google Scholar 

  62. Boyd SD, Raz S, Ehrlich RM. Diabetes insipidus and nonobstructive dilatation of urinary tract. Urology 1980;16:266–269.

    Article  CAS  PubMed  Google Scholar 

  63. Gautier B, Thieblot P, Steg A. Mégauretère, mégavessie et diabkète insipide familial. Sem Hop 1981;57:60–61.

    CAS  PubMed  Google Scholar 

  64. Bichet DG, Razi M, Arthus M-F, Lonergan, M, Tittley P, Smiley RK, Rock G, Hirsch DJ. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism. Kidney Int 1989;36:859–866.

    Article  CAS  PubMed  Google Scholar 

  65. Bichet DG, Hendy GN, Lonergan M, Arthus M-F, Ligier S, Pausova Z, Kluge R, Zingg H, Saenger P, Oppenheimer E, Hirsch DJ, Gilgenkrantz S, Salles JP, Oberlé I, Mandel JL, Gregory MC, Fujiwara TM, Morgan K, Scriver CR. X-linked nephrogenic diabetes insipidus: from the ship Hopewell to restriction fragment length polymorphism studies. Am J Hum Genet 1992;51:1089–1102.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Kambouris M, Dlouhy SR, Trofatter JA, Conneally PM, Hodes ME. Localization of the gene for X-linked nephrogenic diabetes insipidus to Xq28. Am J Med Genet 1988;29:239–246.

    Article  CAS  PubMed  Google Scholar 

  67. Knoers N, van der Heyden H, van Oost BA, Monnens L, Willems J, Ropers HH. Three-point linkage analysis using multiple DNA polymorphic markers in families with X-linked nephrogenic diabetes insipidus. Genomics 1989;4:434–437.

    Article  CAS  PubMed  Google Scholar 

  68. van den Ouweland AM, Knoop MT, Knoers VV, Markslag PW, Rocchi M, Warren ST, Ropers HH, Fahrenholz F, Monnens LA, van Oost BA. Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics 1992;13:1350–1352.

    Article  PubMed  Google Scholar 

  69. Jans DA, van Oost BA, Ropers HH, Fahrenholz F. Derivatives of somatic cell hydrids which carry the human gene locus for nephrogonic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors. J Biol Chem 1990;265:15379–15382.

    CAS  PubMed  Google Scholar 

  70. Cannon JF. Diabetes insipidus clinical and experimental studies with consideration of genetic relationships. Arch Intern Med 1955;96:215–272.

    Article  CAS  Google Scholar 

  71. Bode HH, Crawford JD. Nephrogenic diabetes insipidus in North America: the Hopewell hypothesis. N Engl J Med 1969;280:750–754.

    Article  CAS  PubMed  Google Scholar 

  72. Van Lieburg AF, Verdijk MAJ, Knoers NVAM, van Essen AJ, Proesmans W, Mallmann R, Monnens LAH, van Oost BA, van Os CH, Deen PMT. Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 1994;55:648–652.

    PubMed  PubMed Central  Google Scholar 

  73. Mulders SB, Knoers NVAM, van Lieburg AF, Monnens LAH, Leumann E, Wühl E, Schober E, Rijss JPL, van Os CH, Deen PMT. New mutations in theAQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol 1997;8:242–248.

    CAS  PubMed  Google Scholar 

  74. Canfield MC, Tarnarappoo BK, Moses AM, Verkman AS, Holtzman EJ. Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response. Hum Mol Genet 1997;6(11):1865–1871.

    Article  CAS  PubMed  Google Scholar 

  75. Deen PMT, Verdijk MAJ, Knoers NVAM, Wieringa B, Monnens LAH, van Os CH, van Oost BA. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994; 264:92–95.

    Article  CAS  PubMed  Google Scholar 

  76. Hochberg Z, van Lieburg A, Even L, Brenner B, Lanir N, van Oost BA, Knoers NVAM. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. J Clin Endocrinol Metab 1997;82:686–689.

    CAS  PubMed  Google Scholar 

  77. Vaithinathan R, Berson EL, Dryja TP. Further screening of the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. Genomics 1994;21:461–463.

    Article  CAS  PubMed  Google Scholar 

  78. Schöneberg T, Yun J, Wenkert D, Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide. EMBO J 1996;15:1283–1291.

    PubMed  PubMed Central  Google Scholar 

  79. Schöneberg T, Sandig V, Wess J, Gudermann T, Schultz G. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. J Clin Invest 1997;100(6):1547–1556.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Fushimi K, Sasaki S, Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of aquaporin-2 water channel. J Biol Chem 1997;272(23):14800–14804.

    Article  CAS  PubMed  Google Scholar 

  81. Katsura T, Gustafson C, Ausiello D, Brown D. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PKI cells. Am J Physiol 1997;272(6 Pt2):F817-F822.

    CAS  PubMed  Google Scholar 

  82. Deen PMT, Croes K, van Aubel RAMH, Ginsel LA, van Os CH. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 1995;95:2291–2296.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Tamarappoo BK, Verkman AS. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest 1998; 101(10):2257–2267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Bichet DG, Razi M, Lonergan M, Arthus M-F, Papukna V, Kortas C, Barjon JN. Hemodynamic and coagulation responses to 1-desamino[8-d-arginine]vasopressin (dDAVP) infusion in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 1988;318:881–887.

    Article  CAS  PubMed  Google Scholar 

  85. Van Lieburg AF, Knoers VV, Mallmann F, Proesmans W, van den Heuvel LP, Monnens LA. Normal fibrinolytic responses to 1-desamino-8-d-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene. Nephron 1996; 72(4):544–546.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology Service, Research Center, Hôpital du Sacré-Coeur de Montréal, 5400, Blvd Gouin West, H4J 1C5, Montréal, Québec, Canada

    Daniel G. Bichet & T. Mary Fujiwara

  2. Department of Medicine, University of Montreal, Montreal, Canada

    Daniel G. Bichet & T. Mary Fujiwara

  3. Departments of Human Genetics and Medicine, McGill University, Montreal, Canada

    Daniel G. Bichet & T. Mary Fujiwara

Authors
  1. Daniel G. Bichet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Mary Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Bichet, D.G., Fujiwara, T.M. Diversity of nephrogenic diabetes insipidus mutations and importance of early recognition and treatment. Clin Exper Neph 2, 253–263 (1998). https://doi.org/10.1007/BF02480451

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02480451

Key words

Search

Navigation